The estimated burden of HIV/AIDS in Uganda, 2005-2010

AIDS

Volumn 22, Issue 4, 2008, Pages 503-510

  Hladik, Wolfgang ^a,e   Musinguzi, Joshua ^b   Kirungi, Wilford ^b   Opio, Alex ^b   Stover, John ^c   Kaharuza, Frank ^a   Bunnell, Rebecca ^a   Kafuko, Jessica ^d   Mermin, Jonathan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINISTRY OF HEALTH   (Uganda)

^c AVENIR HEALTH   (United States)

^d US Agency for International Development   (Uganda)

^e Division of Bacterial and Mycotic Diseases   (Uganda)

Author keywords

AIDS; Antiretroviral therapy; Disease burden; HIV; Incidence; Morbidity; Mortality; Prevalence; Uganda

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; NEVIRAPINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG DOSE REGIMEN; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SINGLE DRUG DOSE; UGANDA;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; COST OF ILLNESS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UGANDA;

EID: 39849105058     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f470be     Document Type: Article

References (28)

1. Bond C. AIDS lays waste to Uganda. New Afr 1986: 30-31.
2. Carswell JW, Lloyd G. Rise in prevalence of HIV antibodies recorded at an antenatal booking clinic in Kampala, Uganda. AIDS 1987; 1:192-193.
3. Sewankambo NK, Wawer MJ, Gray RH, Serwadda D, Li C, Stallings RY, et al. Demographic impact of HIV infection in rural Rakai district, Uganda: results of a population-based cohort study. AIDS 1994; 8:1707-1713.
4. Elangot F. Uganda: an AIDS control programme. AIDS Action 1987: p 6. Available at: http://www.aidsaction.info/aa01.html. Accessed: November 2007.
5. Okware SI. Towards a national AIDS-control program in Uganda. West J Med 1987; 147:726-729.
6. Stoneburner RL, Low-Beer D. Population-level HIV declines and behavioral risk avoidance in Uganda. Science 2004; 304:714-718.
7. ORC Macro. Uganda HIV/AIDS Sero-Behavioural Survey 2004/ 5. Kampala, Uganda. Ministry of Health; 2006.
8. Berkley S, Okware S, Naamara W. Surveillance for AIDS in Uganda. AIDS 1989; 3:79-85.
9. Mbulaiteye SM, Mahe C, Whitworth JA, Ruberantwari A, Nakiyingi JS, Ojwiya A, Kamali A. Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study. Lancet 2002; 360:41-46.
10. Whitworth JA, Mahe C, Mbulaiteye SM, Nakiyingi J, Ruberantwari A, Ojwiya A, Kamali A. HIV-1 epidemic trends in rural south-west Uganda over a 10-year period. Trop Med Int Health 2002; 7:1047-1052.
11. Mishra V, Opio A, Cross A, et al. The 2004-2005 Uganda HIV/AIDS Sero-Behavioural Survey: methods and impact of non-response bias. AIDS 2006; 20: In press.
12. UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance. Guidelines for conducting HIV sentinel serosurveys among pregnant women and other groups. Geneva, Switzerland: WHO; 2003.
13. Ghys PD, Brown T, Grassly NC, Garnett G, Stanecki KA, Stover J, Walker N. The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics. Sex Transm Infect 2004; 80 (Suppl. 1):i5-i9.
14. Stover J. Projecting the demographic consequences of adult HIV prevalence trends: the Spectrum Projection Package. Sex Transm Infect 2004; 80 (Suppl. 1):i14-i18.
15. Stover J. AIM Version 4, A computer program for making HIV/ AIDS projections and examining the social and economic impacts of AIDS. Washington, DC, USA: The Futures Group International; 2005.
16. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004; 364:1428-1434.
17. McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS 1999; 13:1687-1695.
18. Guay LA, Hom DL, Mmiro F, Piwowar EM, Kabengera S, Parsons J, et al. Detection of human immunodeficiency virus type 1 (HIV-1) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission. Pediatrics 1996; 98:438-444.
19. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 2003; 362:859-868.
20. Uganda Population and Housing Census. Kampala, Uganda: Uganda Bureau of Statistics; 2002.
21. Namagala ED. AIDS Control Programme. Kampala, Uganda: Ministry of Health; 2006.
22. Nankinga J. AIDS Control Programme. Kampala, Uganda: Ministry of Health; 2006.
23. ORC Macro. Demographic and Health Survey 2000-2001. Entebbe, Uganda: Uganda Bureau of Statistics; 2001.
24. Uganda Bureau of Statistics (UBOS) and MACRO International Inc. Uganda Demographic and Health Survey 2006. Calverton, Maryland, USA; 2006.
25. UNAIDS. Uniting the world against AIDS, Uganda. Geneva, Switzerland: UNAIDS; 2007.
26. Zaba B, Boerma T, White R. Monitoring the AIDS epidemic using HIV prevalence data among young women attending antenatal clinics: prospects and problems. AIDS 2000; 14:1633-1645.
27. STD/AIDS Control Programme. Policy guidelines for prevention of mother-to-child transmission of HIV. Kampala, Uganda: Ministry of Health; June 2006.
28. Sewankambo NK, Gray RH, Ahmad S, Serwadda D, Wabwire-Mangen F, Nalugoda F, et al. Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS 2000; 14:2391-2400.